Discerning how and where products are discounted is an expensive headache for manufacturers
David Weiss, IntegriChain
Advertisement
Articles by David Weiss, IntegriChain
Advertisement
Latest Updated Articles
Use data analytics to monitor 340B discount drug pricingPublished: March 14th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Health Resources & Services Administration Announces Initial Drugs Apart of 340B Rebate Model Pilot Program
2
Improving Pharma Launch Performance With AI-Driven Decision Support
3
Eli Lilly Planning $1.2 Billion Investment in Puerto Rico Manufacturing Site
4
Navigating a Formulary Loss: How One Brand Protected Market Share
5
